FIRST-LINE THERAPY
Clinical trials for FIRST-LINE THERAPY explained in plain language.
Never miss a new study
Get alerted when new FIRST-LINE THERAPY trials appear
Sign up with your email to follow new studies for FIRST-LINE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough stomach cancers: testing a Triple-Threat treatment
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or gastroesophageal cancer that has a specific marker called HER2-positive. The main goals are to find the safest and most effective dose of the new drug fruquintinib when added to two standard ca…
Matched conditions: FIRST-LINE THERAPY
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Triple-Threat therapy tested for aggressive stomach cancers
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or esophageal cancer that has spread. It's for patients who have not yet received treatment for their advanced cancer and whose tumors test positive for two specific markers (HER2 and PD-L1). The …
Matched conditions: FIRST-LINE THERAPY
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC